purchased from Global Inspired Laboratory Co., Ltd. Date of transaction : Within February 2018 Buyer : Bangkok Chain Hospital PCL. Seller : Global Inspired Laboratory Co., Ltd. Relationship with the
of Bangkok Chain Hospital Public Company Limited (the “Company”) No.2/2018, held on 26 February 2018 has passed the resolution to approve the related party transaction as the following details
ที่ BCH No. BCH.174/2017 15 August 2017 Subject : Explanation of the change in operating results of Q2/2017 which exceed 20% To : The President The Stock Exchange of Thailand Bangkok Chain Hospital
ที่ BCH No. BCH.211/2017 8 November 2017 Subject : Explanation of the change in operating results of Q3/2017 which exceed 20% To : The President The Stock Exchange of Thailand Bangkok Chain Hospital
Thailand Bangkok Chain Hospital Public Company Limited (“the Company”) would like to report the operating results of the Company and its subsidiaries for the year ended 31 December 2017 which has been
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.029/2019 28 February 2019 Subject : Explanation of the change in operating results for the year 2018
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.084/2019 13 May 2019 Subject : Management Discussion and Analysis Quarter 1 Ending 31 March 2019 To
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.130/2019 9 August 2019 Subject : Management Discussion and Analysis Quarter 2 Ending 30 June 2019 To
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.064/2018 14 May 2018 Subject : Explanation of the change in operating results of Q1/2018 which exceed
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.106/2018 8 August 2018 Subject : Explanation of the change in operating results of Q2/2018 which